Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Your working Group is pleased to share the information from its scientific meeting, held on the 8 July in Athens :
10:30-10:48 Endothelial function K.Naka
10:48-11:06 Endothelial peripheral arterial tonometry R. Zimlichman 11:06-11:24 Biochemical markers and bioassays U. Landmesser 11:24-11:44 Discussion F. Cosentino
11:44-12:02 Arterial stiffness S. Laurent
12:02-12:20 Brachial-ankle pulse wave velocity A. Yamashina
12:20-12:38 Wave reflections T. Weber
12:38-12:58 Discussion C. Vlachopoulos
12:58-13:16 Intima-media thickness A. Schmidt-Trucksass
13:16-13:34 Ankle-brachial index V.Aboyans
13:34-13:54 Discussion I. Lekakis
BREAK – LIGHT LUNCH 15:00-15:18 The role of vascular biomarkers in hypertension R. Cifkova
15:18-15:36 The role of vascular biomarkers in dyslipidemia and diabetes mellitus D. Mikhailidis
15:36-15:54 Patients with peripheral vascular disease, stroke, renal function impairment M. Brodmann
15:54-16:14 Discussion A. Gallino
16:14-16:32 Macro and microvascular disease: are they facets of the same coin. D. Rizzoni
16:32-16:50 Pharmacological modification of biomarkers and CV risk L. Van Bortel
16:50-17:10 Discussion M. De Carlo
17:10-17:50 General Discussion
17:50-18:00 Handling of the manuscript P. Xaplanteris